Indraprastha Medical Corp
NSE: INDRAMEDCO · Hospital · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹263 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 42.3x in the last 12 months.
- No promoter shares are pledged.
- Operating cash flow was below net profit in 2 of the last 5 years (FY26, FY25).
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 16% of net profit in the last 12 months.
- Debtor days went from 17 (FY24) to 28 (FY26).
- Dividend paid in 4 of the last 5 financial years.
- Price ₹299.95 on 2026-10-26: -53.2% from the 52-week high, 0.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 350 | 325 | 334 | 365 | 381 | 372 | 365 | 406 |
| EBITDA | 64 | 52 | 61 | 73 | 71 | 62 | 61 | 80 |
| OPM % | 18.2% | 16.1% | 18.4% | 20.0% | 18.7% | 16.7% | 16.6% | 19.7% |
| Other income | 6 | 5 | 6 | 7 | 7 | 7 | 7 | 8 |
| Net profit | 42 | 33 | 41 | 51 | 49 | 41 | 42 | 56 |
| EPS (₹) | 4.63 | 3.58 | 4.47 | 5.61 | 5.40 | 4.47 | 4.55 | 6.09 |
| Revenue YoY | +8.9% | +14.4% | +9.3% | +11.3% | ||||
| Profit YoY | +16.7% | +25.0% | +1.7% | +8.5% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 888 | 1,099 | 1,245 | 1,356 | 1,483 | 1,524 |
| EBITDA | 114 | 151 | 193 | 244 | 267 | 274 |
| Net profit | 59 | 86 | 124 | 161 | 184 | 188 |
| EPS (₹) | 6.39 | 9.40 | 13.52 | 17.56 | 20.03 | 20.51 |
| Revenue growth | +23.7% | +13.3% | +9.0% | +9.3% | +10.9% | |
| Profit growth | +47.0% | +43.9% | +29.9% | +14.1% | +12.1% | |
| Dividend / share (₹) | – | 2.50 | 3.00 | 4.50 | 4.50 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +10.5% | +19.3% | +10.9% |
| Net profit | +28.7% | +139.5% | +12.1% |
| EPS | +28.7% | +140.3% | – |
| Share price | – | -14.0% (2y) | -44.9% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 379 | 478 | 597 | 740 |
| Borrowings | – | 0 | 0 | 0 | 0 |
| Cash & equivalents | – | 129 | 224 | 322 | 263 |
| Total assets | – | 555 | 723 | 852 | 991 |
| Fixed assets | – | 274 | 346 | 327 | 364 |
| Capital work in progress | – | 3 | 0 | 33 | 3 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 68 | 58 | 75 | 112 |
| Inventory | – | 8 | 8 | 7 | 8 |
| Payables | – | 98 | 140 | 123 | 128 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 71 | 144 | 200 | 157 | 167 |
| Cash from investing | -51 | -108 | -158 | -111 | -178 |
| Cash from financing | -3 | -26 | -32 | -46 | -46 |
| Capex | 29 | 45 | 69 | 36 | 60 |
| Free cash flow | 42 | 100 | 131 | 120 | 108 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 22.7% | 25.9% | 27.0% | 24.8% |
| ROCE % | – | 32.0% | 35.6% | 37.3% | 34.0% |
| Debtor days | – | 23 | 17 | 20 | 28 |
| Inventory days | – | 16 | 13 | 11 | 11 |
| Payable days | – | 185 | 235 | 194 | 182 |
| Cash conversion cycle (days) | – | -146 | -205 | -163 | -143 |
| Working capital days | – | 31 | 42 | 68 | 61 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 51.00% |
| FIIs | 2.39% |
| DIIs | 1.77% |
| of which Mutual funds | 0.91% |
| Government | 0.00% |
| Public (non-institutions) | 44.84% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% |
| Promoter group | % |
|---|---|
| President of India | 26.00% |
| Apollo Hospitals Enterprise Limited | 22.02% |
| Wedgewood Holdings Limited | 1.61% |
| PCR Investments Limited | 0.42% |
| Pratap C Reddy | 0.26% |
| Preetha Reddy | 0.22% |
| Sucharitha P Reddy | 0.18% |
| Suneeta Reddy | 0.15% |
| Shobhana Kamineni | 0.13% |
| SANGiTA REDDY | 0.01% |
| P V Jayakrishnan | 0.00% |
| K S Baidwan | 0.00% |
| Ramesh Chander | 0.00% |
| Vineeta RAI | 0.00% |
| Public holders above 1% | % |
|---|---|
| Emedlife Insurance Broking Services Limited | 1.70% |
| Citadel Research and Solutions Limited | 1.29% |
| Investor Education and Protection Fund Authority Ministry of Corporate Affairs | 1.07% |
77,706 shareholders. Pledged: 0.00% of promoter shares.
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| INDRAMEDCO | ₹2,750 cr | 14.6x | 3.7x | 28.1% | 34.9% | 18.0% | +10.5% | 1.49% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-18 | Dividend | Dividend - Rs 4 Per Share |
| 2025-09-18 | Dividend | Dividend - Rs 4.50 Per Share |
| 2024-09-13 | Dividend | Annual General Meeting/Dividend - Rs 4.50 Per Share |
| 2023-09-15 | Dividend | Annual General Meeting/Dividend - Rs 3 Per Share |
| 2022-09-15 | Dividend | Annual General Meeting/Dividend - Rs 2.50 Per Share |
| 2021-09-16 | Other | Annual General Meeting |
| 2020-09-17 | Other | Annual General Meeting |
| 2019-09-12 | Dividend | Annual General Meeting/Dividend - Rs 1.60 Per Sh |
| 2018-09-12 | Dividend | Annual General Meeting/Dividend- Rs 1.50 Per Share |
| 2017-09-14 | Dividend | Annual General Meeting/Dividend - Rs 1.80 Per Share |
| 2016-08-18 | Dividend | Annual General Meeting/ Dividend - Rs 1.80/- Per Share |
| 2015-09-16 | Dividend | Annual General Meeting / Dividend Rs 1.80/- Per Share |
| 2014-09-18 | Dividend | Annual General Meeting / Dividend - Rs 1.80/- Per Share |
| 2013-09-19 | Dividend | Annual General Meeting / Dividend - Rs 1.60/- Per Share |
| 2012-09-06 | Dividend | Annual General Meeting And Dividend Rs.1.60 Per Share |
| 2011-09-05 | Dividend | Dividend Rs 1.60 Per Share |
| 2010-08-30 | Dividend | Annual General Meeting And Dividend Rs.1.60 Per Share |
| 2009-08-27 | Dividend | Dividend-Rs.1.50 Pr Share |
| 2008-08-28 | Dividend | Agm/Dividend - 14% |
| 2007-09-07 | Dividend | Agm/Dividend-12.5% |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Hospital activities: The business activities of the Company is running and operating hospitals at Sarita Vihar, New Delhi and Sector-26, Noida.
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | INDRAMEDCO |
| BSE code | 532150 |
| ISIN | INE681B01017 |
| Face value | ₹10.0 |
| Incorporated | 1988-03-16 |
| Website | http://www.apollohospitals.com/delhi |
| Plants (India / abroad) | 0 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.